The Evolution and Future of CAR T Cells for B-Cell Acute Lymphoblastic Leukemia

被引：31
|
作者：
Annesley, Colleen E. [1 ]
Summers, Corinne [1 ]
Ceppi, Francesco [1 ]
Gardner, Rebecca A. [1 ]
机构：
[1] Seattle Childrens Hosp, Seattle, WA 98105 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷 / 04期
关键词：
CHIMERIC ANTIGEN RECEPTORS; CYTOKINE RELEASE SYNDROME; SUSTAINED REMISSIONS; CD19; THERAPY; CD8(+); CHILDREN; PERSISTENCE; MEMORY; CHAIN;
D O I：
10.1002/cpt.950
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Several CAR T designs with CD19 specificity have been associated with consistent responses in clinical trials with complete remission (CR) rates ranging from 70-90%. Relevant challenges remain to be addressed, such as production time, early loss of CAR T cells, relapse due to loss of the target antigen, and prevention of severe cytokine release syndrome and neurotoxicity. This review describes constructs, clinical trial results, side effects, and future direction of CAR T-cell therapy in B-ALL.
引用
收藏
页码：591 / 598
页数：8
相关论文
共 50 条
  • [1] CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
    Saleh, Khalil
    Pasquier, Florence
    Bigenwald, Camille
    De Botton, Stephane
    Ribrag, Vincent
    Castilla-Llorente, Cristina
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [2] Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia
    Ceppi, Francesco
    Gardner, Rebecca A.
    CANCER JOURNAL, 2019, 25 (03) : 191 - 198
  • [3] The future of CAR T-cell therapy for B-cell acute lymphoblastic leukemia in pediatrics and adolescents
    Schultz, Liora
    Mackall, Crystal L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (07) : 633 - 640
  • [4] Clinical experience of CAR T cells for B cell acute lymphoblastic leukemia
    Fabrizio, Vanessa A.
    Curran, Kevin J.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (03)
  • [5] Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
    Canedo, Gustavo de Oliveira
    Roddie, Claire
    Amrolia, Persis J.
    BLOOD ADVANCES, 2025, 9 (04) : 704 - 721
  • [6] Optimizing CAR-T cell therapy in adults with B-cell acute lymphoblastic leukemia
    Agrawal, Vaibhav
    Murphy, Lindsey
    Pourhassan, Hoda
    Pullarkat, Vinod
    Aldoss, Ibrahim
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 236 - 247
  • [7] Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
    Greinix, Hildegard T.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 36 - 42
  • [8] CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia
    Liu, Jun
    Zhang, Xi
    Zhong, Jiang F.
    Zhang, Cheng
    IMMUNOTHERAPY, 2017, 9 (13) : 1115 - 1125
  • [9] Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia
    Leahy, Allison Barz
    Elgarten, Caitlin W.
    Grupp, Stephan A.
    Maude, Shannon L.
    Teachey, David T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 959 - 971
  • [10] Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Pan, Jing
    Lin, Yuehui
    Ling, Zhuojun
    Wu, Tong
    Chen, Dong
    Chang, Alex H.
    Gao, Zhiyong
    Song, Yanzhi
    Zhao, Yongqiang
    Tong, Chunrong
    BLOOD CANCER JOURNAL, 2020, 10 (02)
12345